Pacific Biosciences of California PACB Common stock, shares authorized (in shares)
Common stock, shares authorized (in shares) at other companies
Other financials
Where this comes from
Reported directly by Pacific Biosciences of California in its filing.
Tagged under the XBRL concept us-gaap:CommonStockSharesAuthorized.
The official record: Pacific Biosciences of California’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →
Ask your AI about Pacific Biosciences of California's common stock, shares authorized (in shares).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Pacific Biosciences of California's common stock, shares authorized (in shares)?
- Pacific Biosciences of California (PACB) reported common stock, shares authorized (in shares) of $1B in Q1 2026.
- How has Pacific Biosciences of California's common stock, shares authorized (in shares) changed year-over-year?
- Pacific Biosciences of California's common stock, shares authorized (in shares) decreased by 0.0% year-over-year, from $1B to $1B.
- What is the long-term trend for Pacific Biosciences of California's common stock, shares authorized (in shares)?
- Over 5 years (2020 to 2025), Pacific Biosciences of California's common stock, shares authorized (in shares) has grown at a 0.0% compound annual growth rate (CAGR), from $1B to $1B.